GlassScriptPhysician profile
Anthony Brunetti
NPI 1871145623
$2,150.67
in general payments reported to CMS, 2019-2025
14 companies · $550 in 2025
The $550 reported for 2025 was more than what 82% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.60 · 2022: $789 · 2023: $397 · 2024: $396 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,342.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,083.38 | 2022-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Perform |
| Smith+Nephew, INC. | $212.29 | 2022-2023 | Pico 7 |
| Bioventus LLC | $166.36 | 2021-2025 | Bonescalpel & Sonicone (O.R.), Xcell, Durolane |
| Zimmer Biomet Holdings, INC. | $154.31 | 2022 | |
| Innovation Technologies INC | $145.41 | 2022 | |
| Paragon 28, INC. | $97.03 | 2022 | |
| Pinnacle, INC | $59.51 | 2024-2025 | |
| Fidia Pharma USA INC. | $48.67 | 2022-2024 | Hyalgan |
| Convatec INC. | $37.75 | 2022-2023 | |
| Depuy Synthes Sales INC. | $36.61 | 2024-2025 | Fms, Monovisc |
| Sanofi-Aventis U.S. LLC | $34.50 | 2022-2023 | |
| Polynovo North America LLC | $32.83 | 2025 | Novosorb Btm |
| Treace Medical Concepts, INC. | $23.30 | 2025 | |
| Averitas Pharma INC. | $18.72 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Brunetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.